Huminsulin 30/70 100Iu Penfill 3ml

• HUMINSULIN 30/70 Penfill 3 ml is a premixed human insulin formulation containing 30% short-acting (soluble) insulin and 70% intermediate-acting (isophane) insulin. This combination helps to provide both mealtime and basal insulin coverage in a convenient penfill cartridge for subcutaneous injection. It is designed for individuals with diabetes mellitus who require insulin to control their blood sugar levels.
• The active ingredient in HUMINSULIN 30/70 is human insulin, produced through recombinant DNA technology. This ensures a highly purified and consistent insulin product. The 30% soluble insulin component works rapidly to cover the rise in blood sugar levels after meals, while the 70% isophane insulin component provides a longer-lasting background insulin level to control blood sugar between meals and overnight.
• HUMINSULIN 30/70 is administered subcutaneously using a compatible insulin pen. The penfill cartridge is easily inserted into the pen, and the dose can be accurately dialed. It is typically injected 15-30 minutes before a meal. The dosage is individualized and determined by a healthcare professional based on the patient’s metabolic needs, blood glucose monitoring results, and overall glycemic control goals. Proper injection technique and rotation of injection sites are crucial to avoid lipodystrophy (changes in fat tissue).

Uses of HUMINSULIN 30/70 PENFILL 3 ML

• Treatment of Diabetes Mellitus
• Controlling blood sugar levels
• Management of Type 1 Diabetes
• Management of Type 2 Diabetes (when other medications are not sufficient)
• Management of diabetes in pregnancy (Gestational Diabetes)
• Treatment of Diabetic Ketoacidosis (in conjunction with other treatments)